Wikidata

(Q46723284)

English

Radiation retinopathy is treatable with anti-vascular endothelial growth factor bevacizumab (Avastin).

scientific article published in March 2008

In more languages

Statements

title
Radiation retinopathy is treatable with anti-vascular endothelial growth factor bevacizumab (Avastin). (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18313522
retrieved
24 December 2017
reference URL
http://europepmc.org/abstract/MED/18313522

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q46723284&oldid=1189745519"